149 related articles for article (PubMed ID: 3046633)
1. Ketanserin in essential hypertension. Effects of blood pressure on renal hemodynamics.
Ram CV
Am J Hypertens; 1988 Jul; 1(3 Pt 3):309S-311S. PubMed ID: 3046633
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive therapy with ketanserin: effects on central and renal hemodynamics, and microalbuminuria.
Casagrande P; Valvo E; Bedogna V; Loschiavo C; Giorgetti P; Graziani MS; Maschio G
Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):79-83. PubMed ID: 2307549
[TBL] [Abstract][Full Text] [Related]
3. Renal hemodynamic effects of ketanserin therapy in essential hypertension.
Ram CV; Gonzalez DG; Kaplan NM; Ralakis JM; Henderson JD; Lugo CE; Zachariah N
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S78-80. PubMed ID: 2446078
[TBL] [Abstract][Full Text] [Related]
4. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.
Wenting GJ; Woittiez AJ; Man in't Veld AJ; Schalekamp MA
Hypertension; 1984; 6(1):100-9. PubMed ID: 6319278
[TBL] [Abstract][Full Text] [Related]
5. Ketanserin: a possible tool for studying the role of serotonin in hypertension.
Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035
[TBL] [Abstract][Full Text] [Related]
6. Metabolic and hemodynamic effects of antihypertensive treatment with ketanserin.
Levinson PD; Zimlichman R; Goldstein DS; Brewer HB; Keiser HR
Am J Hypertens; 1988 Jul; 1(3 Pt 3):245S-248S. PubMed ID: 3415801
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive therapy with ketanserin: metabolic and hemodynamic effects.
Levinson PD; Zimlichman R; Goldstein DS; Keiser HR
J Cardiovasc Pharmacol; 1988 Oct; 12(4):384-9. PubMed ID: 2465437
[TBL] [Abstract][Full Text] [Related]
8. The antihypertensive efficacy of ketanserin in the elderly evaluated by ambulatory blood pressure measurement.
McCormack PM; Cox JP; Marron J; Mee F; Atkins N; O'Brien E; O'Malley K
J Hum Hypertens; 1990 Oct; 4(5):565-70. PubMed ID: 2283647
[TBL] [Abstract][Full Text] [Related]
9. [Humoral and hemodynamic (systemic and renal) effects of ketanserin in patients with essential hypertension: what is the role of prostaglandins?].
Lucarini AR
Ann Ital Med Int; 1990; 5(4 Pt 2):464-8. PubMed ID: 2102133
[TBL] [Abstract][Full Text] [Related]
10. Effect of manidipine, a new calcium antagonist, on intrarenal hemodynamics in essential hypertension.
Murakami K; Kimura G; Imanishi M; Sanai T; Kawano Y; Kojima S; Yoshida K; Abe H; Ashida T; Yoshimi H
Blood Press Suppl; 1992; 3():114-8. PubMed ID: 1343278
[TBL] [Abstract][Full Text] [Related]
11. [Effects of chronic antihypertensive treatment with ketanserin versus metoprolol on blood pressure and compliance of great arteries in man: a double-blind crossover study].
Crispino M
Ann Ital Med Int; 1990; 5(4 Pt 2):469-76. PubMed ID: 2102134
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic antihypertensive treatment with ketanserin versus metoprolol on blood pressure and large arteries' compliance in humans: a cross-over double-blind study.
De Luca N; Rosiello G; Crispino M; Volpe M; Galletti P; Buzzetti G; Trimarco B
J Clin Pharmacol; 1988 Apr; 28(4):332-8. PubMed ID: 3292598
[TBL] [Abstract][Full Text] [Related]
13. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive response to ketanserin: influence of race and weight.
Kosoglou T; Cressman MD; Vlasses PH; Rocci ML; Gabos C; Ferguson RK
J Clin Pharmacol; 1988 Nov; 28(11):1017-22. PubMed ID: 3072347
[TBL] [Abstract][Full Text] [Related]
15. Effects of ketanserin on microhemodynamics and hemorheology in patients with essential hypertension.
Konishi M; Sakakura M; Tsushima N
Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():101-4. PubMed ID: 2285638
[TBL] [Abstract][Full Text] [Related]
16. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of acute and chronic effects of ketanserin in the treatment of hypertension and hypothesis on a new mechanism of action].
Sechi LA
Ann Ital Med Int; 1990; 5(4 Pt 2):433-50. PubMed ID: 2102130
[TBL] [Abstract][Full Text] [Related]
18. Renal haemodynamics and sodium excretory capacity during urapidil treatment in patients with essential hypertension.
Lavrijssen AT; Kroon AA; Fuss-Lejeune M; Schiffers PM; de Leeuw PW
J Hypertens; 2000 Jul; 18(7):963-9. PubMed ID: 10930195
[TBL] [Abstract][Full Text] [Related]
19. Effect of nifedipine on renal function in patients with essential hypertension.
Reams GP; Hamory A; Lau A; Bauer JH
Hypertension; 1988 May; 11(5):452-6. PubMed ID: 3366479
[TBL] [Abstract][Full Text] [Related]
20. Renal effects of ketanserin in essential hypertension.
Navis G; de Jong PE; van der Hem GK; de Zeeuw D
J Hypertens Suppl; 1986 Apr; 4(1):S95-8. PubMed ID: 2939222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
